Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Longzhang Oral Liquid (龙掌口含液) is a Traditional Chinese Medicine (TCM) developed and manufactured by Guiyang Xintian Pharmaceutical. The product is formulated as a mouth-holding liquid designed for topical application to the oral mucosa. Its name is derived from its primary active herbal ingredients: Dragon's Blood (Longxuejie, derived from *Dracaena cochinchinensis*) and Rhubarb (Zhangye Dahuang, derived from *Rheum palmatum*). These components provide synergistic anti-inflammatory, analgesic, and antibacterial effects, as well as promoting wound healing. It is primarily indicated for the treatment of recurrent oral ulcers (aphthous stomatitis), gingivitis, periodontitis, and the management of halitosis. The drug is approved and marketed in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Longzhang Oral Liquid.